581616-U

Ascentis^® Phenyl (5 µm) HPLC Columns

L × I.D. 15 cm × 4.6 mm, HPLC Column

• Synonym(e): Phenyl HPLC Column
• UNSPSC-Code: 41115700
• eCl@ss: 32110501
• NACRES: SB.52

Eigenschaften

• product name: Ascentis^® Phenyl HPLC-Säule, 5 μm particle size, L × I.D. 15 cm × 4.6 mm
• Materialien: stainless steel column
• Agentur: suitable for USP L11
• Produktlinie: Ascentis^®
• Leistungsmerkmale: endcapped
• Hersteller/Markenname: Ascentis^®
• Verpackung: 1 ea of
• Kennzeichnungsgrad: 19% Carbon loading
• Parameter: ≤70 °C temp. range; 400 bar pressure (5801 psi)
• Methode(n): HPLC: suitable; LC/MS: suitable
• L × ID: 15 cm × 4.6 mm
• Oberflächenbereich: 450 m²/g
• Oberflächendeckung: 5.2 μmol/m²
• Verunreinigungen: <5 ppm metals
• Matrix: fully porous particle; silica gel high purity, spherical
• Aktive Matrixgruppe: phenyl phase
• Partikelgröße: 5 μm
• Porengröße: 100 Å
• operating pH range: 2-8
• Anwendung(en): food and beverages
• Trenntechnik: reversed phase

Beschreibung

Allgemeine Beschreibung

Die Ascentis Phenyl liefert hervorragende Trennungen im Umkehrphasenmodus, auch in 100% wässrigen Phasen. Sie ist auch für den HILIC/ANP (wässrige Normalphase) Modus geeignet und, aufgrund ihres geringen Blutens auch für Gradienten-Applikationen.

Anwendung

• A Different Perspective on the Characterization of a New Degradation Product of Flibanserin With HPLC-DAD-ESI-IT-TOF-MSn and Its Pharmaceutical Formulation Analysis With Inter-Laboratory Comparison: This study highlights the advanced chromatographic techniques used to characterize pharmaceutical compounds, demonstrating the importance of accurate and detailed analysis in pharmaceutical research. The use of the Ascentis^® Phenyl HPLC column facilitates high-resolution separations, essential for identifying degradation products in complex mixtures (Geven et al., 2023).


• HPLC with Spectrophotometric or Mass Spectrometric Detection for Quantifying Very-Long Chain Fatty Acids in Human Plasma and Its Association with Cardiac Risk Factors: This paper discusses the role of high-performance liquid chromatography (HPLC) in clinical settings, particularly for the assessment of biomarkers related to heart disease. Techniques involving the Ascentis^® Phenyl HPLC column are employed to achieve precise and reliable quantification of fatty acids, critical for clinical diagnostics (Shrestha et al., 2021).


• A Fully Automated and Fast Method Using Direct Sample Injection Combined with Fused-Core Column On-Line SPE-HPLC for Determination of Ochratoxin A and Citrinin in Lager Beers: This study introduces an automated method for toxin analysis in beverages, utilizing the Ascentis^® Phenyl HPLC column. The approach enhances sensitivity and throughput, showcasing the column′s efficacy in food safety applications (Lhotská et al., 2016).


• A Study of Retention Characteristics and Quality Control of Nutraceuticals Containing Resveratrol and Polydatin Using Fused-Core Column Chromatography: The research focuses on nutraceuticals, where the Ascentis^® Phenyl HPLC column′s selectivity plays a pivotal role in segregating and analyzing health-promoting compounds, thereby ensuring product quality and compliance with industry standards (Fibigr et al., 2016).


• An On-Line SPE-HPLC Method for Effective Sample Preconcentration and Determination of Fenoxycarb and Cis, Trans-Permethrin in Surface Waters: This publication illustrates the application of the Ascentis^® Phenyl HPLC column in environmental analysis, particularly for the sensitive detection of pesticides in water bodies. The column′s capabilities help in tracing low-level contaminants, critical for environmental monitoring and protection (Šatínský et al., 2015).

Leistungsmerkmale und Vorteile

• Kompatibel mit 100% wässrigen Lösungen
• ANP/HILIC und Reversed-Phase
• Geringes UV/MS-Bluten, für Gradienten-Applikationen
• Alternative Selektivität

Empfohlene Produkte

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Rechtliche Hinweise

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany